GlassScriptPhysician profile
Brian R Billmeyer
NPI 1376688820
$2,717.39
in general payments reported to CMS, 2019-2025
34 companies · $582 in 2025
The $582 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $657 · 2020: $278 · 2021: $345 · 2022: $96.19 · 2023: $362 · 2024: $397 · 2025: $582.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,341.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,341.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $399.08 | 2019-2024 | Xtandi |
| Neotract INC. | $332.91 | 2019-2020 | |
| Sumitomo Pharma America, INC. | $248.76 | 2023-2025 | Orgovyx, Gemtesa |
| Olympus America INC. | $179.75 | 2019-2025 | Itind System, Soltive |
| Abbvie INC. | $144.04 | 2019-2025 | |
| Janssen Biotech, INC. | $144.02 | 2019-2025 | Erleada |
| Coloplast Corp | $125.77 | 2023-2025 | Porges Coloplast, Speedicath, Coloplast Tfl Drive |
| Urogen Pharma, INC. | $112.83 | 2025 | |
| Hollister Incorporated | $105.53 | 2021 | |
| Boston Scientific Corporation | $97.38 | 2019-2022 | |
| Pfizer INC. | $69.48 | 2019-2025 | |
| Axonics, INC. | $67.82 | 2021-2024 | Axonics, Bulkamid |
| Calyxo, INC. | $65.55 | 2024-2025 | Cvac Aspiration System |
| Ferring Pharmaceuticals INC. | $58.53 | 2019-2024 | Adstiladrin |
| Laborie Medical Technologies Corp. | $50.89 | 2023 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myriad Genetic Laboratories, INC. | $49.09 | 2024-2025 | Prolaris |
| Dendreon Pharmaceuticals LLC | $46.98 | 2020-2022 | |
| Progenics Pharmaceuticals, INC. | $44.20 | 2021-2025 | |
| Amgen INC. | $38.70 | 2019 | |
| Urovant Sciences INC | $38.61 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $37.46 | 2019-2025 | |
| Cardinal Health 414 LLC | $31.23 | 2023 | |
| 180 Medical, INC. | $29.67 | 2025 | Cure Catheter |
| Novartis Pharmaceuticals Corporation | $25.66 | 2023 | |
| Tolmar Pharmaceuticals, INC. | $22.47 | 2021 | |
| Merck Sharp & Dohme LLC | $21.55 | 2024 | Lenvima, Keytruda, Welireg |
| Dornier Medtech America, INC | $20.83 | 2019 | |
| Allergan, INC. | $18.87 | 2019 | |
| Therapeuticsmd, INC. | $18.00 | 2019 | |
| Endo Pharmaceuticals INC. | $15.53 | 2020 | |
| Antares Pharma, INC. | $15.33 | 2019 | |
| Zyla Life Sciences, INC. | $14.27 | 2019 | |
| Dentsply Ih INC. | $13.49 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $13.11 | 2023 | Seglentis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Billmeyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.